MedTrace Logo

Consequences of Admission to the Delivery Room in the Early and Late Phases

NCT06344741 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 248

Last updated 2024-12-30

No results posted yet for this study

Summary

This study will be conducted to compare maternal and neonatal outcomes of pregnant women who applied to the delivery room in the early (latent) and late (active) phase. The population of the research will consist of participants who applied to Darıca Farabi Training and Research Hospital for birth. To determine the sample size of the study, first, those who meet the inclusion criteria and are admitted to the delivery room in the latent phase and those who are accepted in the active phase will be numbered and recruited sequentially. When the number of participants in the 100 latent and 100 active acceptance groups is reached, the effect size will be calculated using the STAI score averages and the G\*Power program, and the exact sample number will be determined, taking into account possible data losses. If necessary, data collection will continue until the target number is reached. Randomization will not be applied in the study. Data will be collected with the maternal and neonatal information form, State and Trait Anxiety Scale (STAI), Fear of Birth Scale, Neonatal Pain and Stress Assessment Scale (ALPS-Neo) and Visual analog scale for birth satisfaction. Data will be collected by the assistant researcher. Statistical analysis will be performed using IBM SPSS Statistic. Descriptive statistical methods will be used to evaluate socio-demographic data, and parametric/nonparametric tests will be used for comparative analyses.

Conditions

  • Fear of Childbirth
  • Neonatal
  • Pain
  • Maternal Distress (During Labor)
  • Satisfaction

Interventions

BEHAVIORAL

Accepted in latent phase

Participants admitted to the delivery room in the latent phase will be included. Routine procedures will be performed.

BEHAVIORAL

Accepted in active phase

Participants admitted to the delivery room in the active phase will be included. Routine procedures will be performed.

Sponsors & Collaborators

  • Kocaeli University

    lead OTHER

Principal Investigators

  • Sena Dilek Aksoy, Ph.D. · Kocaeli University

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-13
Primary Completion
2024-07-15
Completion
2024-07-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06344741 on ClinicalTrials.gov